Alterity Therapeutics(PRNAF)
$0.200.00 (0.00%)
PRNAF
Alterity Therapeutics financials statements
$0.20
At close:0.00 (0.00%)
Alterity Therapeutics (PRNAF) Ratios
7 Followers
Alterity Therapeutics Ratios
PRNAF's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, PRNAF's free cash flow was increased by AU$11.90M and operating cash flow was AU$-11.90M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 14.52 | 12.98 | 3.54 | 6.17 | 7.07 |
| Quick Ratio | 14.52 | 12.98 | 3.54 | 6.17 | 7.07 |
| Cash Ratio | 11.82 | 9.38 | 2.35 | 3.60 | 5.98 |
| Solvency Ratio | -7.07 | -3.31 | -3.50 | -3.04 | -2.17 |
| Operating Cash Flow Ratio | -7.14 | -3.24 | -2.35 | -4.57 | -2.12 |
| Short-Term Operating Cash Flow Coverage | -408.22 | 0.00 | -117.67 | -186.94 | -214.07 |
| Net Current Asset Value | AU$ 42.53M | AU$ 42.25M | AU$ 13.61M | AU$ 22.54M | AU$ 35.25M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.08 | 1.09 | 1.39 | 1.20 | 1.17 |
| Debt Service Coverage Ratio | -449.63 | 0.00 | -182.07 | -164.39 | -303.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.31 | 2.27 | 0.64 | 0.89 | 1.99 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 97.66% | 94.67% | 92.72% | 92.88% |
| EBIT Margin | 0.00% | -269.57% | -487.82% | -449.82% | -340.52% |
| EBITDA Margin | 0.00% | -267.00% | -484.15% | -447.20% | -339.46% |
| Operating Profit Margin | 0.00% | -267.96% | -487.69% | -373.72% | -302.56% |
| Pretax Profit Margin | 0.00% | -222.10% | -474.65% | -349.87% | -249.38% |
| Net Profit Margin | 0.00% | -223.35% | -475.79% | -352.54% | -250.75% |
| Continuous Operations Profit Margin | 0.00% | -223.35% | -475.79% | -352.54% | -250.75% |
| Net Income Per EBT | 87.00% | 100.56% | 100.24% | 100.76% | 100.55% |
| EBT Per EBIT | 94.64% | 82.88% | 97.33% | 93.62% | 82.42% |
| Return on Assets (ROA) | -50.85% | -26.39% | -99.48% | -50.54% | -31.06% |
| Return on Equity (ROE) | -54.77% | -28.65% | -138.60% | -60.52% | -36.22% |
| Return on Capital Employed (ROCE) | -66.30% | -34.30% | -141.53% | -63.81% | -43.62% |
| Return on Invested Capital (ROIC) | -57.61% | -34.25% | -139.37% | -63.22% | -43.47% |
| Return on Tangible Assets | -50.85% | -26.39% | -99.48% | -50.54% | -31.06% |
| Earnings Yield | -19.33% | -18.99% | -104.80% | -81.24% | -41.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 1.38 | 0.99 | 0.45 | 1.10 |
| Payables Turnover | 0.10 | 0.24 | 0.37 | 0.17 | 0.14 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 35.05 | 21.51 | 14.57 | 23.45 |
| Asset Turnover | 0.00 | 0.12 | 0.21 | 0.14 | 0.12 |
| Working Capital Turnover Ratio | 0.00 | 0.19 | 0.22 | 0.14 | 0.16 |
| Cash Conversion Cycle | -3535.51 | -1276.42 | -622.75 | -1391.27 | -2305.02 |
| Days of Sales Outstanding | 0.00 | 264.25 | 367.03 | 806.07 | 332.65 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 3535.51 | 1540.67 | 989.79 | 2197.34 | 2637.67 |
| Operating Cycle | 0.00 | 264.25 | 367.03 | 806.07 | 332.65 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.11 | -0.09 | -0.00 | -0.01 | -0.01 |
| Free Cash Flow Per Share | 0.00 | -0.09 | -0.00 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | -5725624.00 | -2203.05 | -2740.51 | -138.39 |
| Capital Expenditure Coverage Ratio | -1.00 | -5725624.00 | -2203.05 | -2740.51 | -138.39 |
| Operating Cash Flow Coverage Ratio | -116.42 | -73.66 | -79.26 | -95.23 | -105.01 |
| Operating Cash Flow to Sales Ratio | 0.00 | -2.11 | -3.14 | -5.12 | -2.41 |
| Free Cash Flow Yield | 0.00% | -17.90% | -69.11% | -117.94% | -39.73% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.23 | -5.26 | -0.95 | -1.23 | -2.43 |
| Price-to-Sales (P/S) Ratio | 0.00 | 11.76 | 4.54 | 4.34 | 6.10 |
| Price-to-Book (P/B) Ratio | 2.83 | 1.51 | 1.32 | 0.74 | 0.88 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | -5.59 | -1.45 | -0.85 | -2.52 |
| Price-to-Operating Cash Flow Ratio | -5.37 | -5.59 | -1.45 | -0.85 | -2.54 |
| Price-to-Earnings Growth (PEG) Ratio | -0.33 | 0.08 | 0.11 | -0.16 | 0.06 |
| Enterprise Value Multiple | -2.96 | -2.13 | -0.30 | -0.08 | 0.20 |
| Enterprise Value | 83.91M | 30.97M | 5.77M | 1.43M | -3.41M |
| EV to EBITDA | -2.96 | -2.13 | -0.30 | -0.08 | 0.20 |
| EV to Sales | 0.00 | 5.69 | 1.44 | 0.37 | -0.67 |
| EV to Free Cash Flow | 0.00 | -2.70 | -0.46 | -0.07 | 0.27 |
| EV to Operating Cash Flow | -3.73 | -2.70 | -0.46 | -0.07 | 0.28 |
| Tangible Book Value Per Share | 0.20 | 0.33 | 0.00 | 0.01 | 0.01 |
| Shareholders’ Equity Per Share | 0.20 | 0.33 | 0.00 | 0.01 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | -0.01 | -0.00 | -0.01 | -0.01 |
| Revenue Per Share | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.11 | -0.09 | -0.01 | -0.01 | -0.01 |
| Tax Burden | 0.87 | 1.01 | 1.00 | 1.01 | 1.01 |
| Interest Burden | 0.95 | 0.82 | 0.97 | 0.78 | 0.73 |
| Research & Development to Revenue | 0.00 | 2.65 | 4.64 | 3.37 | 2.88 |
| SG&A to Revenue | 0.00 | 1.01 | 1.19 | 1.27 | 1.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.18 | 0.22 | 0.25 | 0.29 |
| Income Quality | 0.96 | 0.94 | 0.66 | 1.45 | 0.96 |
Currency in AUD
